Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California
AJMC,
ABSTRACT Objectives: Direct-acting antivirals (DAAs) for chronic hepatitis C virus (HCV) lead to cure in more than 95% of…
ABSTRACT Objectives: Direct-acting antivirals (DAAs) for chronic hepatitis C virus (HCV) lead to cure in more than 95% of…
In recent years, a growing chorus of patients, providers, and health economics researchers has been calling for a new approach…
Traditional value assessment methods, which rely on the conventional Quality Adjusted Life Year (QALY), have their limitations.